Prostate cancer is one of the most common cancers that occur in men. While it can be life-threatening, the disease is treatable, and the earlier it is detected, the better the treatment outcome.

Prostate-specific antigen (PSA) testing may not accurately pinpoint levels at which transgender women on estrogen therapy may be at risk of developing prostate cancer, according to data from the ...

While a PSA of 12.9 ng/ml does raise concern, it does not automatically mean cancer, noted Dr Saraf. “The risk depends on age ...

TROY, Mich., Sept. 3, 2024 /PRNewswire/ -- During September's Prostate Cancer Awareness Month, the Michigan Institute of Urology wants to stress an important point—0.75. If your prostate-specific ...

February 10, 2023 – Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with ...

The most common screening test for prostate cancer so often returns a false positive result that it's no longer recommended for men older than 70, and it's offered as a personal choice for younger men ...

For decades, it has been known that prostate specific antigen ‒ or PSA ‒ tests are a flawed way to diagnose prostate cancer. Many men have a high PSA without having cancer. Others have low PSA that ...

* New urine biomarker test shows over 90% accuracy in detecting prostate cancer * Test works even when PSA levels appear normal * Biomarker levels drop after //surgery, confirming prostate origin ...